Sitagliptin treatment increases GLP-1 without improving diabetes outcomes after total pancreatectomy with islet autotransplantation

Kendall R. McEachron, Gregory J Beilman, Melena D Bellin

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)958-959
Number of pages2
JournalAmerican Journal of Transplantation
Volume19
Issue number3
DOIs
StatePublished - Mar 2019

Bibliographical note

Funding Information:
K.M. is funded by a NIH T32 grant in pancreas research (T32DK108733; PIs Beilman & Yamamoto). Research reported in this publication was supported by the American Diabetes Association (1-11-CT-06, PI Bellin) and the National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK084315, PI Bellin) as well as National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. Supply of study drug was provided by Merck.

Funding Information:
K.M. is funded by a NIH T32 grant in pancreas research (T32DK108733; PIs Beilman & Yamamoto). Research reported in this publication was supported by the American Diabetes Association (1‐11‐CT‐06, PI Bellin) and the National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK084315, PI Bellin) as well as

Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.

Keywords

  • autotransplantation
  • clinical research/practice
  • clinical trial
  • islet transplantation
  • translational research/science

Cite this